# Treated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple Myeloma

> **NCT00938626** · PHASE1 · COMPLETED · sponsor: **Barbara Ann Karmanos Cancer Institute** · enrollment: 12 (actual)

## Conditions studied

- Multiple Myeloma and Plasma Cell Neoplasm

## Interventions

- **BIOLOGICAL:** anti-CD3 x anti-CD20 bispecific antibody-armed activated T cells
- **PROCEDURE:** autologous hematopoietic stem cell transplantation
- **PROCEDURE:** peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00938626
- **Lead sponsor:** Barbara Ann Karmanos Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2011-10
- **Final completion:** 2013-03
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2013-09-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00938626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00938626, "Treated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple Myeloma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00938626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*